Advancing Pediatric Pancreatic Care with Secretin-Enhanced Imaging

As NASPGHAN approaches, Skip and Wade, on behalf of the ChiRhoClin team, look forward to joining colleagues, clinicians, and researchers from across the pediatric gastroenterology community. We’re eager to connect with partners, share insights, and discuss advances that may help improve outcomes for children with pancreatic disorders!

Secretin Continues to Advance Pediatric Pancreatic Diagnostics

Recent studies are reinforcing the value of secretin-enhanced magnetic resonance cholangiopancreatography (sMRCP) as a powerful, noninvasive tool for evaluating pancreatic structure and function in children. Growing evidence suggests that secretin-enhanced imaging may help clinicians identify pancreatic dysfunction earlier, improve diagnostic accuracy, and guide treatment decisions more effectively. ¹ ³

One of the most significant recent findings comes from a large pediatric cohort study evaluating 201 MRI examinations in children and young adults. Researchers found that quantitative assessment of pancreatic secretory response following secretin administration identified abnormal secretory function in approximately one-third of patients. Importantly, quantitative analysis detected substantially more abnormalities than conventional qualitative interpretation, suggesting that objective measurement may uncover pancreatic dysfunction that might otherwise be missed. ¹

Additional research comparing secretin-enhanced MRCP with endoscopic pancreatic function testing (ePFT), a recognized reference standard for exocrine pancreatic function assessment, demonstrated a strong correlation between post-secretin fluid volumes measured on sMRCP and actual pancreatic fluid secretion collected during ePFT. Children with low pancreatic enzyme activity had reduced secretory responses, smaller pancreatic volumes, and lower post-secretin small bowel fluid increases on imaging. These findings further support sMRCP as a promising noninvasive method for evaluating exocrine pancreatic function in pediatric patients. ³

Beyond Function: Improving Detection of Rare Pancreatic Disorders

Secretin’s value extends beyond functional assessment. Recent case reports have demonstrated how secretin-enhanced imaging can identify rare pancreatic disorders that might otherwise be difficult to diagnose.

In one report, an 11-year-old child with recurrent acute pancreatitis underwent secretin-enhanced MRCP, which revealed abnormal pooling of pancreatic secretions caused by impaired outflow at the papilla of Vater. Subsequent evaluation identified a duodenal diverticulum intermittently compressing the papilla. Surgical correction resulted in complete resolution of pancreatitis, highlighting the diagnostic value of secretin-enhanced imaging in complex cases. ²

Another published case described a child with extensive congenital pancreatic cysts. Secretin-enhanced MRCP not only provided detailed anatomical visualization of the pancreatic cystic lesions but also demonstrated diminished exocrine response. The authors concluded that combining structural and functional information through sMRCP strengthened diagnostic confidence and supported conservative management while avoiding unnecessary surgical intervention. ⁴

Looking Ahead

As the field of pediatric pancreatology continues to evolve, secretin-enhanced imaging is emerging as a valuable bridge between anatomical evaluation and functional assessment. From identifying subtle exocrine insufficiency to uncovering rare congenital and obstructive pancreatic disorders, the latest evidence suggests that secretin-enhanced MRCP may play an increasingly important role in pediatric pancreatic care. ¹⁻⁴

We look forward to seeing everyone at NASPGHAN and continuing the conversation on how innovations like secretin-enhanced imaging can help improve outcomes for children with pancreatic disease.

References

  1. Glenn, A. O., Dudley, J. A., Abu-El-Haija, M., Vitale, D. S., & Trout, A. T. (2026). Assessment of automated pancreatic secretory response measurement in a cohort of pediatric patients. Abdominal Radiology, 51(8), 3821–3829. https://doi.org/10.1007/s00261-025-05364-2
  2. Zeef, D. H., Dwarkasing, R. S., Devos, A. S., Lammers, W. J., Meeussen, C. J. H. M., & Van Waas, M. (2026). Recurrent acute pancreatitis caused by a duodenal diverticulum: The diagnostic value of secretin‐enhanced magnetic resonance cholangiopancreatography. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70553
  3. Fu, Y., Nguyen, H. N., Ponrartana, S., Piester, T. L., Trout, A. T., Alharbi, O., Abu‐El‐Haija, M., & Zheng, Y. (2025). Endoscopic pancreatic function test and other modalities for exocrine pancreatic disease measures. Journal of Pediatric Gastroenterology and Nutrition, 80(5), 847–854. https://doi.org/10.1002/jpn3.70006
  4. De Grande, B., Madeo, A., Pongiglione, M., & Chiaro, A. (2026). Extensive polycystic pancreas in a child: A rare congenital lesion. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70612

*This newsletter is an educational summary prepared for healthcare professionals in gastroenterology and pancreatology. It synthesizes findings from the peer-reviewed literature cited above and is not intended as medical advice, a treatment recommendation, or promotional labeling for any product. Diagnostic performance figures reflect the specific study populations and methods described in each source. ChiRhoStim® is a registered trademark of ChiRhoClin, Inc.